Business Context and Reporting Period
Company: Evolv Technologies Holdings, Inc. (EVLV)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2026
Business Overview: Evolv is a security technology company providing AI-powered screening solutions (Evolv Express and Evolv eXpedite) via a Security-as-a-Service model. The company serves education, healthcare, sports, and industrial sectors. As of March 31, 2026, the company is no longer a smaller reporting company.
Key Financial Metrics
| Metric (in thousands) | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Revenue | $46,328 | $32,007 |
| Gross Profit | $23,599 | $19,150 |
| Gross Margin | 51.0% | 59.8% |
| Net Loss | $(5,009) | $(1,689) |
| Adjusted EBITDA | $3,944 | $2,064 |
| Cash and Cash Equivalents | $56,081 | $25,089 |
| Total Cash, Equivalents & Marketable Securities | $61,073 | $N/A |
| Long-Term Debt (Outstanding) | $30,000 | $0 |
| Net Cash Used in Operating Activities | $(3,179) | $(2,539) |
Note: Q1 2025 cash balance at period end was $25,081. Q1 2026 includes $4,992 in marketable securities.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 45% year-over-year (YoY) to $46.3 million, driven primarily by a 478% increase in Product Revenue ($13.4M vs $2.3M) due to the shift from the distributor license model to the purchase subscription model.
- Subscription Revenue: Increased 20% YoY to $23.1 million, reflecting a growing installed base and pure subscription model adoption.
- License Fee Revenue: Decreased 69% YoY to $1.2 million as the Distribution and License Agreement with Columbia Tech expired on December 31, 2025.
- Operating Expenses: Total operating expenses decreased 4% YoY to $32.1 million, largely due to the absence of $2.7 million in restructuring costs incurred in Q1 2025. General and Administrative expenses decreased 10% due to reduced legal and consulting fees related to prior investigations.
- Net Loss Expansion: Net loss widened to $5.0 million from $1.7 million. This was primarily due to a significant reduction in non-cash gains from the change in fair value of the contingent earn-out liability (which expired in March 2026) and increased interest expense ($0.96M) related to the new term loan.
- Liquidity: Cash and marketable securities increased to $61.1 million, bolstered by the drawdown of a $30.0 million term loan in July 2025 and net cash provided by investing activities ($9.8M) in Q1 2026.
Guidance, Outlook, Risks, and Unusual Items
- Key Metrics: Annual Recurring Revenue (ARR) grew 20% YoY to $127.3 million. Remaining Performance Obligation (RPO) was $299.0 million as of March 31, 2026.
- Debt Covenants: The company is in full compliance with its MidCap Credit Agreement covenants, including a minimum ARR of $107.3 million. A minimum EBITDA covenant will take effect on June 30, 2027.
- Legal Proceedings:
- Class Action: A settlement in principle of $15.0 million has been reached (preliminary approval granted April 2026), with an estimated $14.3 million insurance recovery.
- Derivative Suits: Agreements in principle reached to settle three derivative lawsuits involving corporate governance reforms and a $1.3 million fee payment by insurance carriers.
- SEC/DOJ: The DOJ investigation concluded in August 2025. The SEC investigation into marketing practices remains ongoing.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of March 31, 2026, due to material weaknesses in the control environment, risk assessment, and IT general controls. These weaknesses contributed to prior financial restatements.
- Supply Chain: The company entered a new contract manufacturing agreement with Plexus Corp. in November 2025 to diversify supply and reduce reliance on a single manufacturer.
Investor Verification Checklist
- Internal Control Remediation: Verify the progress of the remediation plan for material weaknesses in internal controls over financial reporting, specifically regarding IT general controls and segregation of duties.
- Legal Settlement Finalization: Monitor the final court approval of the $15.0 million class action settlement and the $1.3 million derivative suit fee to confirm the net financial impact and insurance recoveries.
- Debt Covenant Compliance: Track quarterly ARR performance to ensure continued compliance with the minimum ARR covenant ($107.3M+), which increases quarterly.
- Revenue Model Transition: Assess the sustainability of the shift from the distributor license model to the purchase subscription model and its impact on gross margins and recurring revenue stability.
- SEC Investigation Status: Monitor updates regarding the ongoing SEC investigation into marketing practices for potential fines or injunctive relief.